Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor
Identifiers
Identifiers
Date issued
2013Journal title
Clinical & Translational Oncology
Type of content
Artigo